AOD-9604

Precision Fat Loss—No Hormone Trade-Offs

5mg

$55.00

Injectable

SKU: AOD-5MG

Lipolysis fragment of HGH

Key Benefits

Selective activation of fat tissue receptors
May promote breakdown of stored fat
Supports inhibition of new fat formation
Preferential effects on adipose tissue
Minimal impact on muscle tissue
Sustained activity for 6-8 hours
Avoids unwanted anabolic effects

Finally Burn Stubborn Fat Without Crashing Your Hormones

Most people trying to lose fat end up tanking their hormones and feeling like garbage. This changes that equation entirely. You get aggressive fat mobilization without the metabolic crash—so you can actually stay lean long-term instead of yo-yoing back.

Adipose tissue metabolism / Beta-3 adrenergic receptor activation and AMPK-mediated lipolysis

About AOD-9604

AOD-9604 is a selective fragment of growth hormone engineered to target fat cells specifically. It activates the same fat-burning pathways as HGH but without affecting muscle growth, blood sugar, or other hormonal systems. This means you get targeted fat loss without the complexity and side effects of full hormone replacement.

Who It's For

Ideal for clients who want serious fat loss results without disrupting their existing hormone protocols or risking metabolic dysfunction. Works particularly well for stubborn fat areas and can be integrated into comprehensive body composition programs. The selective targeting makes it suitable for long-term use in protocols focused on maintaining lean body composition.

Research Background

AOD-9604 represents a targeted approach to harnessing growth hormone's fat-burning properties while avoiding unwanted side effects. This synthetic peptide works by activating beta-3 adrenergic receptors in fat tissue and stimulating AMPK pathways, which together promote the breakdown of stored fat (lipolysis) while preventing new fat formation (lipogenesis). Unlike full growth hormone, AOD-9604 doesn't significantly increase IGF-1 levels or affect blood sugar, making it a more selective tool for body composition management. Research has focused on three primary areas: 1) Understanding its selective receptor binding that targets fat cells specifically, 2) Optimizing dosing protocols for maximum fat loss with minimal side effects, and 3) Evaluating long-term safety in various populations. While promising preclinical and early human studies suggest potential benefits for fat loss and metabolic health, AOD-9604 remains investigational and requires additional clinical validation before regulatory approval.

Dosing Protocol

Reference dosing and protocol planning

Level	Dose	Frequency	Notes
Beginner	250 mcg	Daily	Initial dosing to assess tolerance
Intermediate	300-500 mcg	Daily	Standard protocol after tolerance established
Advanced	500-1000 mcg	Daily	Enhanced protocol for experienced researchers
Maximum	2 mg	Daily	Maximum therapeutic range

Default:Daily

Timing:AM/Pre-workout

Dilution:1 mL

Select a dosing level and click Calculate to plan your protocol.

Dosing Level

Protocol Duration

12 weeks

4 wk12 wk24 wk

Daily (7.0 doses/week × 12 weeks = 84 total doses)

Selected vial: 5mg(5 mg per vial)

Vials Required

33.6 mg needed ÷ 5 per vial

Total Investment

$385

$55.00 per vial

Per Dose

0.08 mL

8 units on U-100 syringe

Doses per Vial

5 ÷ 0.40 mg/dose

* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.

Compliance & Disclaimer

This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.